Bacteriotherapy for inflammatory bowel disease
Abstract The number of patients with inflammatory bowel disease is rapidly increasing in developed countries. The main cause of this increase is thought not to be genetic, but secondary to rapidly modernized environmental change. Changes in the environment have been detrimental to enteric probiotics...
Main Authors: | Yusuke Yoshimatsu, Yohei Mikami, Takanori Kanai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41232-020-00153-4 |
Similar Items
-
The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent <i>Clostridioides difficile</i> Infection: A Retrospective Cohort Study
by: Camilla Kara Svensson, et al.
Published: (2022-10-01) -
Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis model
by: Faith D. Ihekweazu, et al.
Published: (2019-07-01) -
Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
by: Teena Chopra, et al.
Published: (2023-01-01) -
Recovery of Fecal Microbiome and Bile Acids in Healthy Dogs after Tylosin Administration with and without Fecal Microbiota Transplantation
by: Margaux Marclay, et al.
Published: (2022-06-01) -
Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
by: Chun-Wei Chiu, et al.
Published: (2021-05-01)